| OF THE WORLD HEALTH ORGANIZATION CLASSIFICATION OF TUMORS OF THE HEMATOPOIETIC AND LYMPHOID TISSUES JK Choi, W Xiao, X Chen, S Loghavi, KS Elenitoba-Johnson, KN Naresh, ... Modern Pathology, 100466, 2024 | 20733 | 2024 |
| World Health Organization classification of tumours of haematopoietic and lymphoid tissues SH Swerdlow, E Campo, NL Harris, ES Jaffe, SA Pileri, H Stein, J Thiele, ... Lyon: IARC press, 2008 | 2294 | 2008 |
| The 5th edition of the World Health Organization classification of haematolymphoid tumours: myeloid and histiocytic/dendritic neoplasms JD Khoury, E Solary, O Abla, Y Akkari, R Alaggio, JF Apperley, R Bejar, ... leukemia 36 (7), 1703-1719, 2022 | 2203 | 2022 |
| The 5th edition of the World Health Organization classification of haematolymphoid tumours: lymphoid neoplasms R Alaggio, C Amador, I Anagnostopoulos, AD Attygalle, IBO Araujo, ... Leukemia 36 (7), 1720-1748, 2022 | 1969 | 2022 |
| The genetic landscape of mutations in Burkitt lymphoma C Love, Z Sun, D Jima, G Li, J Zhang, R Miles, KL Richards, CH Dunphy, ... Nature genetics 44 (12), 1321-1325, 2012 | 686 | 2012 |
| Genetic heterogeneity of diffuse large B-cell lymphoma J Zhang, V Grubor, CL Love, A Banerjee, KL Richards, PA Mieczkowski, ... Proceedings of the National Academy of Sciences 110 (4), 1398-1403, 2013 | 637 | 2013 |
| Histopathological findings and viral tropism in UK patients with severe fatal COVID-19: a post-mortem study B Hanley, KN Naresh, C Roufosse, AG Nicholson, J Weir, GS Cooke, ... The Lancet Microbe 1 (6), e245-e253, 2020 | 583 | 2020 |
| 100,000 genomes pilot on rare-disease diagnosis in health care—preliminary report 100,000 Genomes Project Pilot Investigators New England Journal of Medicine 385 (20), 1868-1880, 2021 | 427 | 2021 |
| Deep sequencing of the small RNA transcriptome of normal and malignant human B cells identifies hundreds of novel microRNAs DD Jima, J Zhang, C Jacobs, KL Richards, CH Dunphy, WWL Choi, ... Blood, The Journal of the American Society of Hematology 116 (23), e118-e127, 2010 | 265 | 2010 |
| Mesenchymal stem cells of cord blood origin are effective at preventing but not treating graft-versus-host disease V Tisato, K Naresh, J Girdlestone, C Navarrete, F Dazzi Leukemia 21 (9), 1992-1999, 2007 | 250 | 2007 |
| Consolidation radiation after complete remission in Hodgkin's disease following six cycles of doxorubicin, bleomycin, vinblastine, and dacarbazine chemotherapy: is there a need? S Laskar, T Gupta, S Vimal, MA Muckaden, TK Saikia, SK Pai, KN Naresh, ... Journal of Clinical Oncology 22 (1), 62-68, 2004 | 244 | 2004 |
| Distribution of various subtypes of non-Hodgkin's lymphoma in India: a study of 2773 lymphomas using REAL and WHO Classifications KN Naresh, V Srinivas, CS Soman Annals of oncology 11, S63-S67, 2000 | 213 | 2000 |
| Clinical features and outcome in HIV-associated multicentric Castleman's disease M Bower, T Newsom-Davis, K Naresh, S Merchant, B Lee, B Gazzard, ... Journal of Clinical Oncology 29 (18), 2481-2486, 2011 | 200 | 2011 |
| In situ mantle cell lymphoma: clinical implications of an incidental finding with indolent clinical behavior A Carvajal-Cuenca, LF Sua, NM Silva, S Pittaluga, C Royo, JY Song, ... Haematologica 97 (2), 270, 2012 | 197 | 2012 |
| EBNA3B-deficient EBV promotes B cell lymphomagenesis in humanized mice and is found in human tumors RE White, PC Rämer, KN Naresh, S Meixlsperger, L Pinaud, C Rooney, ... The Journal of clinical investigation 122 (4), 2012 | 192 | 2012 |
| Poly (ADP-ribose) polymerase family member 14 (PARP14) is a novel effector of the JNK2-dependent pro-survival signal in multiple myeloma A Barbarulo, V Iansante, A Chaidos, K Naresh, A Rahemtulla, G Franzoso, ... Oncogene 32 (36), 4231-4242, 2013 | 187 | 2013 |
| Hormone receptor status of breast cancer in India: a study of 798 tumours SB Desai, MT Moonim, AK Gill, RS Punia, KN Naresh, RF Chinoy The breast 9 (5), 267-270, 2000 | 183 | 2000 |
| Enteropathy-associated T cell lymphoma subtypes are characterized by loss of function of SETD2 AB Moffitt, SL Ondrejka, M McKinney, RE Rempel, JR Goodlad, CH Teh, ... Journal of Experimental Medicine 214 (5), 1371-1386, 2017 | 175 | 2017 |
| Clinical drug resistance linked to interconvertible phenotypic and functional states of tumor-propagating cells in multiple myeloma A Chaidos, CP Barnes, G Cowan, PC May, V Melo, E Hatjiharissi, ... Blood, The Journal of the American Society of Hematology 121 (2), 318-328, 2013 | 166 | 2013 |
| Histological and immunophenotypic profile of nasal NK/T cell lymphomas from Peru: high prevalence of p53 overexpression L Quintanilla-Martinez, JL Franklin, I Guerrero, L Krenacs, KN Naresh, ... Human pathology 30 (7), 849-855, 1999 | 160 | 1999 |
